The Queen’s Medical Center is proud to announce it has completed its 1,000th ION Navigational procedure, marking a major milestone since becoming the first in the state to offer this innovative technology in lung cancer care in October 2022.
The ION Navigational platform is a fully robotic, minimally invasive procedure for the evaluation of lung nodules that might have gone undetected or treated at a later stage.
ION, along with Hawaiʻi’s first AI nodule detection program, is part of the cutting-edge Queen’s Advanced Lung Institute; a multi-disciplinary team of experts committed to early diagnosis and providing high-quality lung cancer care to our community, where patients can be diagnosed, staged, and treated in one setting.
“We’ve really sped up the timeline from diagnosis to treatment, and that’s a real game changer for our patients,” explained Taryne Imai, MD, Program Director, QMC Thoracic Surgery.
“At the end of the day, our program is about giving patients a better chance of diagnosis, a better chance at a cure, and a better chance at living long, healthy lives,” said Brad Tokeshi, MD, Medical Director, QMC Pulmonary Medicine.
According to the American Cancer Society, lung cancer is the leading cause of cancer deaths for both men and women in Hawaiʻi and across the U.S.
For more information about Queen’s Advanced Lung Institute, click here or call 808-686-LUNG (5864).
